scispace - formally typeset
A

Angela Leung

Researcher at Tufts Medical Center

Publications -  8
Citations -  190

Angela Leung is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Internal medicine & Live birth. The author has an hindex of 3, co-authored 5 publications receiving 82 citations. Previous affiliations of Angela Leung include Beth Israel Deaconess Medical Center & Harvard University.

Papers
More filters
Journal ArticleDOI

Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine.

TL;DR: The findings may serve to reassure transgender patients and their care providers that outcomes can be excellent even if testosterone therapy has already been initiated and whether similar results can be achieved without stopping testosterone therapy.
Journal ArticleDOI

How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach

TL;DR: It is demonstrated that one fresh cycle with high oocyte yield is an optimal way to plan IVF treatment and with modern cryopreservation methods, the concept of "one-and-done" could safely achieve ≥2 live births with just one stimulation cycle in almost a quarter of patients.
Journal ArticleDOI

A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection

TL;DR: A trinational retrospective cohort study was performed of 31,191 oocyte cryopreservation cycles and 972 oocyte thaw (OT) cycles undertaken in the USA (2010-2016) and 3673 oocyte and 517 OT cycles in Australia/New Zealand (Aus/NZ; 2010-2015) as mentioned in this paper.
Journal ArticleDOI

Perinatal outcomes in singleton pregnancies after in vitro fertilization cycles over 24 years.

TL;DR: In this article, a retrospective cohort of 14,424 Singleton live births resulting from all IVF cycles from August 1, 1995 to October 31, 2019 was used to determine how a shift in clinical practice along with laboratory changes has impacted singleton perinatal outcomes after autologous in vitro fertilization (IVF) cycles.